921
Views
33
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells

, , &
Pages 748-764 | Received 24 Jan 2010, Accepted 15 Apr 2010, Published online: 21 Sep 2010

References

  • What are the key statistics about prostate cancer? American Cancer Society 2009. Available from: http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_prostate_cancer_36.asp (updated 7 July 2009; cited 18 January 2010).
  • Stern JM, Stanfield J, Kabbani W, Hsieh JT, Cadeddu JA. Selective prostate cancer thermal ablation with laser activated gold nanoshells. J Urol 2008; 179: 748–753
  • Mertyna P, Goldberg W, Yang W, Goldberg SN. Thermal ablation: A comparison of thermal dose required for radiofrequency-, microwave-, and laser-induced coagulation in an ex vivo bovine liver model. Acad Radiol 2009; 16: 1539–1548
  • Yerushalmi A, Servadio C, Leib Z, Fishelovitz Y, Rokowsky E, Stein JA. Local hyperthermia for treatment of carcinoma of the prostate: A preliminary report. Prostate 1982; 3: 623–630
  • Johannesen M, Gneveckow U, Thiesen B, Taymorrian K, Cho CH, Waldofner N, Scholz R, Jordan A, Loening SA, Wust P. Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution. Eur Urol 2007; 52: 1653–1662
  • Horsman MR, Overgaard J. Hyperthermia: A potent enhancer of radiotherapy. Clin Oncol 2007; 19: 418–426
  • van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JDP, van Putten WLJ, Hart AAM. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: A prospective randomised multicentre trial. Lancet 2000; 355: 1119–1125
  • Gilligan T, Kantoff PW. Chemotherapy for prostate cancer. Urology 2002; 60: 94–100
  • Calabro F, Sternberg CN. Current indications for chemotherapy in prostate cancer patients. Eur Urol 2007; 51: 17–26
  • Potters L, Fearn P, Kattan MW. External radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer. Brachytherapy 2002; 1: 36–41
  • Monrow AT, Faricy PO, Jennings SB, Biggers RD, Gibbs GL, Peddeda AV. High-dose-rate brachytherapy for large prostate volumes (>50cc) – Uncompromised dosimetric coverage and acceptable toxicity. Brachytherapy. 2008; 7: 7–11
  • Ponce AM, Vujaskovic Z, Yuan F, Needham D, Dewhirst MW. Hyperthermia mediated liposomal drug delivery. Int J Hyperthermia 2006; 22: 205–213
  • Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007; 2: 751–760
  • Bidwell GL, III, Davis AN, Fokt I, Priebe W, Raucher D. A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance. Invest New Drugs 2007; 25: 313–326
  • Oden JT, Diller KR, Bajaj C, Browne JC, Hazle J, Babuska I, Bass J, Demkowicz L, Feng Y, Feuentes D, Prudhomme S, Rylander MN, Stafford RJ, Zhang Y. Development of a computational paradigm for laser treatment of cancer. Lect Notes Comput Sci 2006; 3993: 530–537
  • Madersabacher S, Grobl M, Kramer G, Dirnhoger S, Steiner G, Marberger M. Regulation of heat shock protein 27 expression of prostastic cells in response to heat treatment. Prostate 1998; 37: 174–181
  • Rylander MN, Diller KR, Wang S, Aggarwal S. Correlation of HSP70 expression and cell viability following thermal stimulation of bovine aortic endothelial cells. J Biomech Eng 2005; 127: 751–757
  • Rylander MN, Feng Y, Bass J, Diller KR. Coordinated modeling of thermal stress induced cell injury and heat shock protein expression. Ann N Y Acad Sci 2005; 1066: 222–242
  • Wang S, Xie W, Rylander MN, Tucker PW, Aggarwal S, Diller KR. HSP70 kinetics study by continuous observation of HSP-GFP fusion protein expression on a perfusion heating stage. Biotechnol Bioeng 2007; 99: 146–154
  • Vertrees RA, Jordan JM, Zwischenberger JB. Hyperthermia and chemotherapy: The science. Current Clinical Oncology: Intraperitoneal Cancer Therapy, CW Helm, RP Edwards. Humana Press, Totowa 2007; 71–100
  • Vargus-Roig LM, Fanelli MA, Lopez LA, Gago FE, Tello O, Aznar JC, Ciocca DR. Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect Prev 1997; 21: 441–451
  • Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y, Foster CS. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 2000; 60: 7099–7105
  • Richards EH, Hickey E, Weber L, Masters JR. Effects of over-expression of small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells. Cancer Res 1996; 56: 2446–2451
  • Ciocca DR, Clark GM, Tandon AK, Fuqua SAN, Welch WJ, Mc Guire WL. Heat shock protein HSP70 in patients with axillary lymph node-negative breast cancer: Prognostic implications. J Natl Cancer Inst 1993; 85: 570–574
  • Fuqua SA, Oesterreich S, Hilsenbeck SG, Von Hoff DD, Eckardt J, Osborne CK. Heat shock proteins and drug resistance. Breast Cancer Res Treat 1994; 32: 67–71
  • Landriscina M, Amoroso MR, Piscazzi A, Esposito F. Heat shock proteins, cell survival and drug resistance: The mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. Gynecol Oncol 2009
  • Tomei LD, Cope FO. Apoptosis: The Molecular Basis of Cell Death. Cold Spring Harbor, New York 1991
  • Gibbons NB, Watson RWG, Coffey RNT, Brady HP, Fitzpatrick JM. Heat-shock proteins inhibit induction of prostate cancer cell apoptosis. Prostate 2000; 45: 58–65
  • Creagh EM, Sheehan D, Cotter TG. Heat shock proteins – Modulators of apoptosis in tumour cells. Leukemia 2000; 14: 1161–1173
  • Garrido C, Solary E. A role of HSPs in apoptosis through ‘protein triage’?. Cell Death Differ 2003; 10: 619–620
  • Takayama S, Reed JC, Homma S. Heat-shock proteins as regulators of apoptosis. Oncogene 2003; 22: 9041–9047
  • Levine AJ, Momand J, Finlay CA. The p53 tumor supressor gene. Nature 1991; 351: 453–456
  • Ciocca DR, Calderwood SK. Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005; 10: 86–103
  • Mehlen P, Kretz-Remy C, Preville X, Arigo AP. Human HSP27, Drosophillia HSP27, and human alpha B-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins agaisnt TNF-alpha-induced cell death. EMBO J 1996; 15: 2695–2706
  • Singh J, Kaur G. Hsp70 induction and oxidative stress protection mediated by a subtoxic dose of NMDA in the retinoic acid-differentiated C6 glioma cell line. Brain Res Bull 2006; 69: 37–47
  • Oesterreich S, Weng CN, Qiu M, Hilsenbeck SG, Fuqua SAW. The small heat shock protein HSP27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res 1993; 53: 4442–4448
  • Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock proteins in cancer: Chaperones of tumorigenesis. Trends Biochem Sci 2006; 31: 164–172
  • Franzen B, Linder S, Alaiya AA, Erikson E, Fujioka K, Bergman AC, Jornvall H, Auer G. Analysis of polypeptide expression in benign and malignant human breast lesions. Electrophoresis 1997; 18: 582–587
  • Van Buskirk AM, Enagel DC, Guagliardi LE. Cellular and sub-cellular distribution of HSP72/74: A peptide-binding protein that plays a role in antigen processing. J Immunol 1991; 146: 500–510
  • Srivastava PK, Udono H, Blachere NE, Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 1994; 39: 93–100
  • Menoret A, Patry Y, Burg C, Pendu JL. Co-segregation of tumor immunogenicity with expression of inducible but not constitive Hsp70 in rat colon carcinomas. J Immunol 1995; 155: 740–748
  • Wei Y, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. Induction of autologous tumor killing by heat treatment of fresh human tumor cell: Involvement of gd T cells and heat shock protein 70. Cancer Res 1996; 56: 1104–1113
  • Udono H, Srivastava PK. Heat shock protein associated peptides elicit specific cancer immunity. J Exp Med 1986; 178: 1391–1398
  • Chant ID, Rose PE, Morris AG. Analysis of heat shock protein expression in myeloid leukemia cells by flow cytometry. Br J Haematol 1995; 90: 163–168
  • Barnes JA, Dix DJ, Collins BW, Luft C, Allen JW. Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia. Cell Stress Chaperones 2001; 6: 316–325
  • Beckham JT, Wilmink GJ, Mackanos MA, Takahashi K, Contag CH, Takahashi T, Jansen ED. Role of Hsp70 in cellular thermotolerance. Laser Surg Med 2008; 40: 704–715
  • Georgopoulous C, Welch WJ. Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol 1993; 9: 601–634
  • Craig EA, Weissman JS, Horwich AL. Heat shock proteins and molecular chaperones: Mediators of protein conformation and turnover in the cell. Cell 1994; 78: 365–372
  • Kurahashi T, Miyake H, Hara I, Fujisawa M. Expression of major heat shock proteins in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. J Urol 2007; 177: 757–761
  • Tiara T, Narita T, Iguchi-Ariga H. A novel G1-specific enhancer identified in the human heat shock protein 70 gene. Nucleic Acids Res 1997; 25: 1975–1983
  • Daugaard M, Jaattela M, Rohde M. Hsp70-2 is required for tumor cell growth and survival. Cell Cycle 2005; 4: 877–880
  • O’Connel-Rodwell CE, Shriver D, Simanovskii DM, Mcclure C, Cao YA, Zhang W, Bachmann MH, Beckham JT, Jansen ED, Palanker D, Schwettman HA, Contag CH. A genetic reporter of thermal stress defines physiologic zones over a defined temperature range. FASEB J 2004; 18: 264–271
  • Beckham JT, Mackanos MA, Crooke C, Takahashi T, O'Connel-Rodwell C, Contag CH, Jansen ED. Assessment of cellular response to thermal laser injury through bioluminescence imaging of heat shock protein 70. Photochem Photobiol 2004; 79: 76–85
  • O’Connel-Rodwell CE, Mackanos MA, Simanovskii DM, Cao YA, Bachmann MH, Schwettman HA, Contag CH. In vivo analysis of heat-shock-protein-70 induction following pulsed laser irradiation in transgenic reporter mouse. J Biomed Opt 2008; 13: 030501
  • Rieger TR, Morimoto RI, Hatzimanikatis V. Mathematical modeling of the eukaryotic heat-shock response: Dynamics of the Hsp70 promoter. Biophys J 2005; 88: 1646–1658
  • Wang S, Aggarwal S, Diller KR. Heat shock protein 70 expression kinetics. J Biomech Eng 2003; 125: 794–797
  • Burke A, Ding X, Singh R, Kraft RA, Rylander MN, Szot C, Buchanan C, Whitney J, Fisher J, Levi-Polyachenko N, Hatchr HC, D'Agostino R, Jr, Nock N, Ajayan PM, Carroll DL, Torti FM, Torti SV. Rapid thermal treatment of kidney tumors with multi-walled carbon nanotubes results in long term survival. Proc Natl Acad Sci U.S.A. 2009; 4: 12897–12902
  • Fisher J, Rylander MN. Effective cancer laser therapy design through the integration of nanotechnology and computational treatment planning models. Proc SPIE 2008; 68690D.1–68690D.11
  • Jolly C, Morimoto RI. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 2000; 92: 1564–1572
  • Feige U, Mollenhauer J. Heat shock proteins. Introduction. Cell Mol Life Sci 1992; 48: 621–622
  • Rylander MN, Feng Y, Zhang Y, Bass J, Stafford RJ, Volgin A, Hazle JD, Diller KR. Optimizing heat shock protein expression induced by prostate cancer laser therapy through predictive computational models. J Biomed Opt 2006; 11: 041113
  • Rylander MN, Feng Y, Bass J, Diller KR. Thermally induced injury and heat-shock protein expression in cells and tissues. Ann N Y Acad Sci 2005; 1066: 222–242
  • Feng YS, Oden JT, Rylander MN. A two-state cell damage model under hyperthermic conditions: Theory and in vitro experiments. J Biomech Eng 2008; 130: 0410161–10
  • Henriques FC. Studies of thermal injury, V. The predictability and the significance of thermally induced rate processes leading to irreversible epidermal injury. Arch Pathol 1947; 43: 489–502
  • Mambula SS, Calderwood SK. Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. J Immunol 2006; 177: 7849–7857
  • Wissing D, Jaattela M. Hsp27 and Hsp70 increase the survival of WEHI-S cells exposed to hyperthermia. Int J Hyperthermia 1996; 12: 125–138
  • Roti JLR, Kampinga HH, Malyapa RS, Wright WD, vanderWaal RP, Xu M. Nuclear matrix as a target for hyperthermic killing of cancer cells. Cell Stress Chaperones 1998; 3: 245–255
  • Tang D, Khaleque MD, Jones EL, Theirault JR, Li C, Wong WH, Stevenson MA, Calderwood SK. Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones 2005; 10: 46–58
  • Moriyama-Gonda N, Igawa M, Shiina H, Urakami S, Shigeno K, Terashima M. Modulation of heat-induced cell death in PC-3 prostate cancer cells by the antioxidant inhibitor diethyldithiocarbamate. B J U Int 2002; 90: 317–325
  • Ciocca DR, Fuqua SAW, Locklim S, Toft DO, Welch WJ, Mcguire WL. Response of human breast cancer cells to heat-shock and chemotherapeutic drugs. Cancer Res 1992; 52: 3648–3654
  • Wang SH, Diller KR, Aggarwal SJ. Kinetics study of endogenous heat shock protein 70 expression. J Biomech Eng - Trans ASME 2003; 125: 794–797
  • Bhowmick S, Swanlund DJ, Bischof JC. Supraphysiological thermal injury in Dunning AT-1 prostate tumor cells. J Biomech Eng - Trans ASME 2000; 122: 51–59
  • Bhowmick S, Hoffman NE, Bischof JC. Thermal therapy of prostate tumor tissue in the dorsal skin flap chamber. Microvasc Res 2002; 64: 170–173
  • Bhowmick SJ, Coad E, Swanlund DJ, Bischof JC. In vitro thermal therapy of AT-1 Dunning prostate tumours. Int J Hyperthermia 2004; 20: 73–92
  • Bischof JC, Padanilam J, Holmes WH, Ezzell RM, Lee RC, Tompkins RG, Yarmush ML, Toner M. Dynamics of cell-membrane permeability changes at supraphysiological temperatures. Biophys J 1995; 68: 2608–2614

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.